Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
The liposome is the first nanomedicine transformed into the market and applied to human patients. Since then, such phospholipid bilayer vesicles have undergone technological advancements in delivering small molecular-weight compounds and biological drugs. Numerous investigations about liposome uses...
Saved in:
Main Authors: | Yonglong He (Author), Wanting Zhang (Author), Qingqing Xiao (Author), Lifang Fan (Author), Dechun Huang (Author), Wei Chen (Author), Wei He (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adapting liposomes for oral drug delivery
by: Haisheng He, et al.
Published: (2019) -
Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
by: Guangqu Liu, et al.
Published: (2021) -
Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy
by: Yongguang Gao, et al.
Published: (2023) -
Delivery strategies of amphotericin B for invasive fungal infections
by: Xiaochun Wang, et al.
Published: (2021) -
Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy
by: Dongliang Cheng, et al.
Published: (2022)